Director of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), Bristol James Arthur, sells 14,700 shares worth $644,411
According to Deciphera Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Apr 14 04:00 PM, company Director, Bristol James Arthur disclosed selling 14,700 shares at a cost of $43.84. At the time of this transaction (Apr 12), this trade was worth $644,411 in total. As of Apr 12, Bristol James Arthur now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Director, Bristol James Arthur, we have the following information:
- SEC Form 4 filing: Jan 15: Sold 7,000 shares at the rate of $50.29 per share. Total worth of this trade was $352,039. Total number of shares owned as of Jan 15 were 0
- SEC Form 4 filing: Oct 09: Sold 23,541 shares at the rate of $53.57 per share. Total worth of this trade was $1,261,069. Total number of shares owned as of Oct 09 were 0
- SEC Form 4 filing: Jul 09: Sold 23,541 shares at the rate of $54.99 per share. Total worth of this trade was $1,294,634. Total number of shares owned as of Jul 09 were 0
Posted by
George Daniels
on Wednesday April 14 2021, 6:39 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
